🌍 New WHO Guidance on GLP-1 Therapies: A Turning Point in Obesity Care 💉📘
The latest JAMA report highlights a pivotal moment in global health: the WHO's evidence-informed guideline on GLP-1 therapies for adults living with obesity. With over 1 billion people affected worldwide, this chronic, relapsing disease demands integrated, equitable, lifelong care.
The guidance underscores two essentials:
💊 Long-term GLP-1 therapy for those living with obesity
🤝 Intensive behavioral support to amplify and sustain benefits
But the message is clear—medication alone is not enough. True progress requires strong health systems, equitable access, and person-centered prevention and care.
A timely call to action for clinicians, policymakers, and health leaders everywhere. 🌱🌐
